GGrantIndex
Sort

326,823 grants matching clinical trial

Trial to Assess Chelation Therapy (TACT)

$6,207,279
Mount Sinai Medical Center (Miami Beach) · U01 · FY2002 · AT

Oregon Clinical and Translational Research Institute

$6,206,437
David H. Ellison · Oregon Health & Science University · UL1 · FY2018 · TR

STORAGE AND DISTRIBUTION OF CLINICAL AGENTS

$6,200,000
Mehrinfar Mahzad · Fisher Bioservices, Inc. · N02 · FY2025 · CA

Development and Production of HIV Vaccines and Adjuvants

$6,197,003
Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2020 · AI

BEST-CLI Trial-DCC

$6,194,631
Flora Sandra Siami · New England Research Institutes, Inc. · U01 · FY2016 · HL

Core B - Facility Maintenance and Operation Core

$6,194,524
Thomas Gary Ksiazek · University Of Texas Med Br Galveston · UC7 · FY2025 · AI

EMS Network Data Coordinating Center

$6,193,836
Scott Emerson · University Of Washington · U01 · FY2006 · HL

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$6,191,525
Ronald J Sokol · University Of Colorado Denver · UL1 · FY2008 · RR

KARABELO Clinical Trials Unit for NIAID Networks

$6,186,290
Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2020 · AI

Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages

$6,183,078
Barton F Haynes · Duke University · U19 · FY2022 · AI

VA-Perry Point Cooperative Studies Program

$6,182,980
National Institute On Drug Abuse · Y01 · FY2016 · DA

Development of Mutivalent Filovirus (Ebola and Marburg) Vaccines

$6,180,074
Javad Aman · Integrated Biotherapeutics, Inc. · N01 · FY2009 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$6,179,160
Garret A Fitzgerald · University Of Pennsylvania · UL1 · FY2011 · RR

Phase III double-blind, randomized controlled trial of suvorexant versus placebo to treat insomnia in persons with opioid use disorder

$6,175,490
Andrew S Huhn · Johns Hopkins University · U01 · FY2024 · DA

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of mRNA, Lipid Nanoparticle Based HIV Immunogens

$6,174,301
Wendell Beres · Duke University · N01 · FY2023 · AI

Established Status Epilepticus Treatment Trial (ESETT)

$6,170,975
Jaideep Kapur · University Of Virginia · U01 · FY2014 · NS

Oregon Clinical and Translational Research Institute

$6,170,823
David H. Ellison · Oregon Health & Science University · UL1 · FY2019 · TR

Oregon Clinical and Translational Research Institute

$6,169,893
David H. Ellison · Oregon Health & Science University · UL1 · FY2017 · TR

Resuscitation Outcomes Consortium (ROC) Data Coordinating Center

$6,169,555
Susanne May · University Of Washington · U01 · FY2012 · HL

GH16-002, Botswana: Impact Evaluation of Combination HIV Prevention Interventions

$6,169,497
Myron E Essex · Harvard School Of Public Health · U2G · FY2016 · GH

NRG Oncology Network Group Operations Center

$6,169,294
Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2021 · CA

Randomized Trial of a Multifactorial Fall Injury Prevention Strategy

$6,167,288
Shalendar Bhasin · Brigham And Women'S Hospital · U01 · FY2015 · AG

Household Air Pollution and Health: A Multi-Country LPG Intervention Trial

$6,167,184
Thomas F Clasen · Emory University · UM1 · FY2016 · HL

University of Michigan Comprehensive Cancer Center Support Grant

$6,166,044
Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2017 · CA

Clinical Trials Monitoring Service

$6,164,378
Barry Anderson · Theradex Systems, Inc. · N02 · FY2019 · CA